NCT01365611View on ClinicalTrials.gov

Open Label Study to Assess the Pharmacokinetics of Intranasal Ketorolac Tromethamine Following Fluticasone Propionate in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

May 31, 2007

Study Completion Date

March 31, 2008

Conditions
Healthy Subjects
Interventions
DRUG

Ketorolac tromethamine

A single intranasal dose of 30 mg ketorolac tromethamine was administered to all subjects on Days 1 and 6.

DRUG

Fluticasone Propionate

Daily intranasal dose of 200 ug fluticasone propionate on Days 2-6

Trial Locations (1)

Unknown

ICON Development Solutions, Manchester

Sponsors

Lead Sponsor

Egalet Ltd
All Listed Sponsors
lead

Egalet Ltd

INDUSTRY